HZNP logo

HZNP Cash From Financing

Annual CFF

-$347.96 M
-$1.82 B-123.67%

December 31, 2022

Summary

Performance

1-Year Change

-123.67%

3-Year Change

-19.8%

5-Year Change

-741.09%

15-Year Change

-741.09%

HZNP Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

4.88%
HZNP annual cash flow from financing activities is higher than 4.88% of companies in Healthcare sector

High & Low

All-time High

$1.47 B
HZNP annual cash flow from financing activities is currently -123.67% below its historical high of $1.47 billion

3-Year Low

-$347.96 M
HZNP annual cash flow from financing activities is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
HZNP previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
HZNP next annual earnings announcement has not yet been scheduled

OtherHZNPcash flowmetrics:

Annual CFI

-$134.00 M
HZNP annual cash flow from investing activities is -$134.00 million

Annual CFO

$1.26 B
HZNP annual cash flow from operations is $1.26 billion

Annual FCF

$1.13 B
HZNP annual free cash flow is $1.13 billion

Annual CAPEX

$126.28 M
HZNP annual capital expenditures is $126.28 million

Quarterly CFF

$9.03 M
+$97.16 M+110.25%

June 30, 2023

Summary

Performance

3-Month Change

+110.25%

1-Year Change

-48.13%

3-Year Change

-55.87%

5-Year Change

+137.93%

HZNP Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

84.84%
HZNP quarterly cash flow from financing activities is higher than 84.84% of companies in Healthcare sector

High & Low

All-time High

$1.47 B
HZNP quarterly cash flow from financing activities is currently -99.39% below its historical high of $1.47 billion

3-Year Low

-$160.97 M

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2023
HZNP previous earnings announcement was published on Jun 30, 2023

Next Quarterly Earnings Report Date

N/A
HZNP next earnings announcement has not yet been scheduled

OtherHZNPcash flowmetrics:

Quarterly CFI

-$20.03 M
HZNP quarterly cash flow from investing activities is -$20.03 million

Quarterly CFO

$161.47 M
HZNP quarterly cash flow from operations is $161.47 million

Quarterly FCF

$143.00 M
HZNP quarterly free cash flow is $143.00 million

Quarterly CAPEX

$18.47 M
HZNP quarterly capital expenditures is $18.47 million

TTM CFF

-$334.43 M
-$8.38 M-2.57%

June 30, 2023

Summary

Performance

3-Month Change

-2.57%

1-Year Change

-266.85%

3-Year Change

-373.89%

5-Year Change

-15.14%

HZNP TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

6.2%
HZNP TTM cash flow from financing activities is higher than 6.2% of companies in Healthcare sector

High & Low

All-time High

$2.41 B
HZNP TTM cash flow from financing activities is currently -113.86% below its historical high of $2.41 billion

3-Year Low

-$347.96 M

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2023
HZNP previous earnings announcement was published on Jun 30, 2023

Next Quarterly Earnings Report Date

N/A
HZNP next earnings announcement has not yet been scheduled

OtherHZNPcash flowmetrics:

TTM CFI

-$142.87 M
HZNP TTM cash flow from investing activities is -$142.87 million

TTM CFO

$1.04 B
HZNP TTM cash flow from operations is $1.04 billion

TTM FCF

$906.13 M
HZNP TTM free cash flow is $906.13 million

TTM CAPEX

$134.52 M
HZNP TTM capital expenditures is $134.52 million

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

HZNP Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-123.7%-48.1%-266.9%
3 y3 years-19.8%-55.9%-373.9%
5 y5 years-741.1%+137.9%-15.1%

HZNP Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-123.7%at low-48.1%+105.6%-122.8%+3.9%
5 y5-year-123.7%at low-99.4%+105.6%-113.9%+4.6%
alltimeall time-123.7%at low-99.4%+103.5%-113.9%+4.6%

Horizon Therapeutics Public Limited Cash From Financing History

DateAnnualQuarterlyTTM
Jun 2023
-
$9.03 M(-110.3%)
-$334.43 M(+2.6%)
Mar 2023
-
-$88.13 M(-45.3%)
-$326.05 M(-6.3%)
Dec 2022
-$347.96 M(-123.7%)
-$160.97 M(+70.6%)
-$347.96 M(+96.3%)
Sep 2022
-
-$94.37 M(-641.9%)
-$177.28 M(+94.5%)
Jun 2022
-
$17.42 M(-115.8%)
-$91.16 M(-16.4%)
Mar 2022
-
-$110.04 M(-1233.0%)
-$109.11 M(-107.4%)
Dec 2021
$1.47 B(+62.5%)
$9.71 M(-217.6%)
$1.47 B(+0.4%)
Sep 2021
-
-$8.26 M(+1463.4%)
$1.46 B(-38.8%)
Jun 2021
-
-$528.00 K(-100.0%)
$2.39 B(-0.9%)
Mar 2021
-
$1.47 B(>+9900.0%)
$2.41 B(+166.8%)
Dec 2020
$904.58 M(-411.4%)
$4.10 M(-99.6%)
$904.58 M(-0.9%)
Sep 2020
-
$919.63 M(+4392.3%)
$912.87 M(-1393.5%)
Jun 2020
-
$20.47 M(-151.7%)
-$70.57 M(-79.9%)
Mar 2020
-
-$39.61 M(-419.8%)
-$350.68 M(+20.7%)
Dec 2019
-$290.45 M(+1650.1%)
$12.39 M(-119.4%)
-$290.45 M(-1.0%)
Sep 2019
-
-$63.81 M(-75.4%)
-$293.29 M(+29.1%)
Jun 2019
-
-$259.64 M(-1359.1%)
-$227.11 M(-2708.1%)
Mar 2019
-
$20.62 M(+116.0%)
$8.71 M(-152.5%)
Dec 2018
-$16.60 M(-130.6%)
$9.54 M(+304.4%)
-$16.60 M(-63.6%)
Sep 2018
-
$2.36 M(-109.9%)
-$45.53 M(-1.2%)
Jun 2018
-
-$23.82 M(+408.6%)
-$46.09 M(+114.2%)
Mar 2018
-
-$4.68 M(-75.9%)
-$21.52 M(-139.6%)
Dec 2017
$54.28 M(-91.7%)
-$19.39 M(-1174.3%)
$54.28 M(-92.6%)
Sep 2017
-
$1.80 M(+140.3%)
$732.43 M(+0.2%)
Jun 2017
-
$751.00 K(-98.9%)
$730.78 M(-0.2%)
Mar 2017
-
$71.11 M(-89.2%)
$732.45 M(+11.5%)
Dec 2016
$657.07 M
$658.76 M(>+9900.0%)
$657.07 M(>+9900.0%)
Sep 2016
-
$151.00 K(-93.8%)
$204.00 K(-92.2%)
Jun 2016
-
$2.42 M(-156.8%)
$2.61 M(-99.7%)
DateAnnualQuarterlyTTM
Mar 2016
-
-$4.27 M(-325.2%)
$1.04 B(-27.9%)
Dec 2015
$1.44 B(+326.4%)
$1.89 M(-25.8%)
$1.44 B(-0.3%)
Sep 2015
-
$2.55 M(-99.8%)
$1.45 B(-17.0%)
Jun 2015
-
$1.04 B(+160.9%)
$1.74 B(+144.6%)
Mar 2015
-
$398.50 M(+6206.3%)
$712.63 M(+110.7%)
Dec 2014
$338.29 M(+407.1%)
$6.32 M(-97.9%)
$338.29 M(-15.5%)
Sep 2014
-
$298.55 M(+3123.4%)
$400.43 M(+297.0%)
Jun 2014
-
$9.26 M(-61.7%)
$100.87 M(+11.0%)
Mar 2014
-
$24.16 M(-64.7%)
$90.87 M(+36.2%)
Dec 2013
$66.72 M(-59.4%)
$68.46 M(-6878.3%)
$66.72 M(-4210.7%)
Sep 2013
-
-$1.01 M(+37.4%)
-$1.62 M(-102.0%)
Jun 2013
-
-$735.00 K(<-9900.0%)
$80.19 M(-1.0%)
Mar 2013
-
$0.00(-100.0%)
$80.96 M(-50.7%)
Dec 2012
$164.31 M(+197.9%)
$122.00 K(-99.8%)
$164.31 M(+0.1%)
Sep 2012
-
$80.80 M(>+9900.0%)
$164.22 M(+28.6%)
Jun 2012
-
$41.00 K(-100.0%)
$127.68 M(-5.3%)
Mar 2012
-
$83.34 M(>+9900.0%)
$134.82 M(+144.4%)
Dec 2011
$55.15 M(+85.3%)
$39.00 K(-99.9%)
$55.15 M(+1.8%)
Sep 2011
-
$44.26 M(+516.6%)
$54.17 M(+142.3%)
Jun 2011
-
$7.18 M(+95.1%)
$22.36 M(-33.8%)
Mar 2011
-
$3.68 M(-489.3%)
$33.78 M(+13.5%)
Dec 2010
$29.76 M(+151.3%)
-$945.00 K(-107.6%)
$29.76 M(-18.7%)
Sep 2010
-
$12.45 M(-33.1%)
$36.62 M(+14.5%)
Jun 2010
-
$18.60 M(-5491.9%)
$31.97 M(+161.1%)
Mar 2010
-
-$345.00 K(-105.8%)
$12.24 M(+3.4%)
Dec 2009
$11.84 M(-34.2%)
$5.91 M(-24.2%)
$11.84 M(+99.7%)
Sep 2009
-
$7.80 M(-792.8%)
$5.93 M(-416.7%)
Jun 2009
-
-$1.13 M(+50.9%)
-$1.87 M(+150.9%)
Mar 2009
-
-$746.00 K
-$746.00 K
Dec 2008
$18.00 M
-
-

FAQ

  • What is Horizon Therapeutics Public Limited annual cash flow from financing activities?
  • What is the all time high annual CFF for Horizon Therapeutics Public Limited?
  • What is Horizon Therapeutics Public Limited annual CFF year-on-year change?
  • What is Horizon Therapeutics Public Limited quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Horizon Therapeutics Public Limited?
  • What is Horizon Therapeutics Public Limited quarterly CFF year-on-year change?
  • What is Horizon Therapeutics Public Limited TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Horizon Therapeutics Public Limited?
  • What is Horizon Therapeutics Public Limited TTM CFF year-on-year change?

What is Horizon Therapeutics Public Limited annual cash flow from financing activities?

The current annual CFF of HZNP is -$347.96 M

What is the all time high annual CFF for Horizon Therapeutics Public Limited?

Horizon Therapeutics Public Limited all-time high annual cash flow from financing activities is $1.47 B

What is Horizon Therapeutics Public Limited annual CFF year-on-year change?

Over the past year, HZNP annual cash flow from financing activities has changed by -$1.82 B (-123.67%)

What is Horizon Therapeutics Public Limited quarterly cash flow from financing activities?

The current quarterly CFF of HZNP is $9.03 M

What is the all time high quarterly CFF for Horizon Therapeutics Public Limited?

Horizon Therapeutics Public Limited all-time high quarterly cash flow from financing activities is $1.47 B

What is Horizon Therapeutics Public Limited quarterly CFF year-on-year change?

Over the past year, HZNP quarterly cash flow from financing activities has changed by -$8.38 M (-48.13%)

What is Horizon Therapeutics Public Limited TTM cash flow from financing activities?

The current TTM CFF of HZNP is -$334.43 M

What is the all time high TTM CFF for Horizon Therapeutics Public Limited?

Horizon Therapeutics Public Limited all-time high TTM cash flow from financing activities is $2.41 B

What is Horizon Therapeutics Public Limited TTM CFF year-on-year change?

Over the past year, HZNP TTM cash flow from financing activities has changed by -$243.27 M (-266.85%)